David Pelizzon

Track

Insider profile

Currently holds a position at OrthoPediatrics Corp

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
15 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 44%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Director OrthoPediatrics Corp Jan. 1, 2011 -
David Pelizzon's trades of OrthoPediatrics Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
309.47
Quantity 82,947 +23.6%
Value US$4,897,184
Transaction date
Purchase
Price
5.89
Quantity 16,978 +5.4%
Value US$100,000
Transaction date
Purchase
Price
5.67
Quantity 8,818 +2.9%
Value US$49,998
Transaction date
Purchase
Price
15.24
Quantity 3,100 +1.1%
Value US$47,244
Transaction date
Purchase
Price
11.41
Quantity 4,366 +1.5%
Value US$49,816
Transaction date
Purchase
Price
13.00
Quantity 5,425 +1.9%
Value US$70,525
Transaction date
Purchase
Price
15.25
Quantity 120,000 +80.6%
Value US$1,830,000
Transaction date
Purchase
Price
46.50
Quantity 3,700 +21.5%
Value US$172,050
Transaction date
Purchase
Price
15.93
Quantity 695 +0.5%
Value US$11,071
Transaction date
Purchase
Price
15.50
Quantity 4,003 +2.8%
Value US$62,046
Transaction date
Purchase
Price
11.11
Quantity 8,100,810 +245.9%
Value US$89,999,999
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-10
S Sale
96,307 -11.1%
365.75
US$859,442 		96,307 -11.1% 365.75 US$859,442
2026-09-10 2026-09-10
S Sale
82,947 +23.6%
309.47
US$4,897,184 		82,947 +23.6% 309.47 US$4,897,184
2026-09-04 2026-09-02
S Sale
95,739 +21.9%
200.63
US$3,494,943 		95,739 +21.9% 200.63 US$3,494,943
2026-09-01 2026-09-01
S Sale
10,131 -0.2%
23.10
US$234,026 		10,131 -0.2% 23.10 US$234,026
2026-09-01 2026-08-28
S Sale
326,700 -4.8%
23.04
US$7,527,168 		326,700 -4.8% 23.04 US$7,527,168
2026-08-26 2026-08-26
S Sale
18,000 -0.3%
24.28
US$437,040 		18,000 -0.3% 24.28 US$437,040
2026-08-26 2026-08-25
S Sale
16,300 -0.2%
24.74
US$403,262 		16,300 -0.2% 24.74 US$403,262
2026-08-26 2026-08-24
S Sale
4,000 -0.1%
25.75
US$103,000 		4,000 -0.1% 25.75 US$103,000
2025-12-18 2025-12-16
S Sale
250,000 -2.3%
19.66
US$4,915,000 		250,000 -2.3% 19.66 US$4,915,000
2025-12-10 2025-12-09
S Sale
28,834 -0.3%
21.03
US$606,379 		28,834 -0.3% 21.03 US$606,379
2025-12-10 2025-12-08
S Sale
221,166 -2.0%
21.20
US$4,688,719 		221,166 -2.0% 21.20 US$4,688,719
2025-11-25 2025-11-24
S Sale
250,000 -2.2%
20.62
US$5,155,000 		250,000 -2.2% 20.62 US$5,155,000
2025-11-14 2025-11-12
S Sale
250,000 -2.2%
20.80
US$5,200,000 		250,000 -2.2% 20.80 US$5,200,000
2024-08-26 2024-08-23
B Purchase
16,978 +5.4%
5.89
US$100,000 		16,978 +5.4% 5.89 US$100,000
2024-08-26 2024-08-22
B Purchase
8,818 +2.9%
5.67
US$49,998 		8,818 +2.9% 5.67 US$49,998
2023-03-15 2023-03-13
B Purchase
3,100 +1.1%
15.24
US$47,244 		3,100 +1.1% 15.24 US$47,244
2021-11-15 2021-11-11
B Purchase
4,366 +1.5%
11.41
US$49,816 		4,366 +1.5% 11.41 US$49,816
2021-11-12 2021-11-11
B Purchase
825 +3.7%
66.48
US$54,846 		825 +3.7% 66.48 US$54,846
2021-11-10 2021-11-08
B Purchase
5,425 +1.9%
13.00
US$70,525 		5,425 +1.9% 13.00 US$70,525
2021-05-12 2021-05-10
B Purchase
120,000 +80.6%
15.25
US$1,830,000 		120,000 +80.6% 15.25 US$1,830,000
2021-03-17 2021-03-15
B Purchase
3,700 +21.5%
46.50
US$172,050 		3,700 +21.5% 46.50 US$172,050
2021-03-10 2021-03-08
B Purchase
695 +0.5%
15.93
US$11,071 		695 +0.5% 15.93 US$11,071
2021-03-10 2021-03-08
B Purchase
4,003 +2.8%
15.50
US$62,046 		4,003 +2.8% 15.50 US$62,046
2021-03-03 2021-03-01
B Purchase
8,100,810 +245.9%
11.11
US$89,999,999 		8,100,810 +245.9% 11.11 US$89,999,999